Skip to main content
. 2021 Jul 28;7(31):eabg7073. doi: 10.1126/sciadv.abg7073

Fig. 8. Schematic illustration of the oncogenic function of the METTL3-HMBOX1 axis.

Fig. 8

Overexpression of METTL3 in human cancer leads to augmented m6A signals on HMBOX1. Alteration to this particular m6A epitranscriptomic program facilitates the degradation of HMBOX1 mRNAs, causes progressive telomere shortening, inactivates p53 signaling, and eventually generates genomic instability in cancer cells, which drives the full malignant progression.